AXL and COVID-19: Considering Axl’s role in regulating EMT, Stewart and coworkers hypothesized that reverting EMT using Axl inhibitors such as bemcentinib, which displays a proven in vitro antiviral efficacy against SARS-CoV-2, could represent an attractive option to limit COVID-19 severity [91].